6 Data Linkage Use Cases to Future-Proof Your Clinical Trial

By Medidata

Clinical trials are essential for medical regulatory decisions, but trial patients also generate valuable real-world data (RWD) through interactions with healthcare systems. This RWD, including medical records and wearable device data, complements clinical trial data (CTD) to offer deeper insights into treatment benefits, risks, and costs.

Historically, concerns over patient privacy have hindered the integration of clinical trials and RWD, delaying access to vital data and insights. However, new tokenization technologies are bridging this gap, allowing sponsors to link CTD with RWD at the patient level. This integration provides a more comprehensive view of patient trajectories and outcomes, addressing critical evidence gaps and enabling new applications in patient tracking, treatment effectiveness, and long-term safety monitoring.

Medidata Link offers a centralized solution for connecting patient-level CTD and RWD across multiple research sites. Integrated with the Medidata Clinical Cloud platform, it ensures secure data management, compliance, and scalability. Features include:

- Scalable PII ingestion for centralized processing of personally identifying information.
- Secure data management with industry-leading tokenization, ensuring patient privacy.
- Continuous evidence generation through various use cases, with options for further analytics through Medidata AI.

Download to find out more.

Enter your details to receive the free white paper:

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.